Abstract
Background In July 2022 it was estimated 2 million people in the UK have self-reported Long Covid (LC).1 Many people have reported not receiving adequate healthcare support. There is a lack of research which provides an in-depth exploration of the barriers faced by people with LC in accessing healthcare support. It is important to understand these barriers to provide better support, care and advice for those experiencing LC.
Objective To understand the barriers faced in accessing primary, secondary and specialist healthcare support for people with LC.
Design and participation 40 interviews were conducted with people with LC alongside 12 interviews with healthcare professionals (HCPs) providing LC support in Bradford, as part of a UK wide qualitative longitudinal study.
Results People living with LC had a large degree of difficulty in accessing healthcare services for LC support. We categorised the healthcare access experiences of participants into five main types: 1) being unable to access primary care 2) accessing primary care but receiving (perceived) inadequate support 3) extreme persistence 4) alternatives to mainstream healthcare 5) positive experiences. There was a severe lack of access to specialist LC services. Ethnic minority participants faced a further barrier of mistrust and fear of services deterring them from accessing support. HCPs discussed systemic barriers to delivering services. Experiences were embedded in macro structural issues further exacerbated by the pandemic.
Conclusion To better support people with LC the barriers faced in accessing healthcare support must be addressed. Of significance, improvements to GP access are required; especially as GPs are the first line of support for people living with LC.
Patient and public involvement A PPI group is engaged at regular intervals in the project.
Patient and Public Contribution
Designing an interview schedule for people with LC: The wider CONVALSCENCE research project has a PPI group involved in various work packages. The PPI group is hosted by researchers at University of West of England who have expertise in patient and public involvement. Members of the PPI group all have or had LC. After an extensive literature review4, a draft of the interview schedule was presented to the group via a workshop. It was then revised after incorporating their feedback and piloted by the research team for further refinement.
Data interpretation workshop: Following advice of the UWE researchers, the PPI group were presented ahead of time with 4 interview transcripts from the dataset and provided their interpretation of the interviews via a workshop. The theme of barriers to accessing healthcare was also highlighted by attendees, for example they discussed patients being disbelieved (particularly young people) and fragmented services as some points of interest within the transcripts.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Characterisation, determinants, mechanisms and consequences of the long-term effects of COVID-19: providing the evidence base for health care services (CONVALESCENCE) was funded by NIHR (COV-LT-0009). This research team is working on the Qualitative component of the work package, a qualitative longitudinal study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study has been ethically reviewed and given a favourable opinion by University of York Health Sciences Research Governance Committee on 01/10/21 (ref: HSRGC/2021/466/B)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
